Patents by Inventor Luke David Burke

Luke David Burke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platelet Adhesion Reduction Cardiovascular Graft
    Publication number: 20240245498
    Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.
    Type: Application
    Filed: April 2, 2024
    Publication date: July 25, 2024
    Inventors: Luke David Burke, Martijn Antonius Johannes Cox, Aurelie Serrero
  • Method of using a cardiovascular graft to reduce thrombosis or platelet adhesion
    Patent number: 11980535
    Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: May 14, 2024
    Assignee: Xeltis AG
    Inventors: Luke David Burke, Martijn Antonius Johannes Cox, Aurelie Serrero
  • Inhibition of Platelet Absorption
    Publication number: 20210177567
    Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.
    Type: Application
    Filed: February 24, 2021
    Publication date: June 17, 2021
    Inventors: Luke David Burke, Martijn Antonius Johannes Cox, Aurelie Serrero
  • Inhibition of Platelet Absorption
    Publication number: 20180325646
    Abstract: A cardiovascular graft is provided with highly reduced thrombogenicity. The cardiovascular graft is an electrospun non-woven mesh produced from supramolecular polymers with large diameter fibers. The cardiovascular graft can be implemented as a vascular graft into the human body to allow vascular bypass/reconstruction, or repeated venous access for dialysis treatment, as well as other disorders of small-diameter blood vessels.
    Type: Application
    Filed: June 12, 2018
    Publication date: November 15, 2018
    Inventors: Luke David Burke, Martijn Antonius Johannes Cox, Aurelie Serrero